Bloomberg Law
Pharma & Life Sciences
LinkedIn

AIM Vaccine Gets US FDA Nod for Trial of mRNA Herpes Zoster Shot

March 23, 2025, 11:52 AM UTC
Felix Tam
Felix Tam
Bloomberg News

US Food and Drug Administration has approved clinical trial for mRNA herpes zoster vaccine, AIM Vaccine says in a filing to HKEX.

To contact the reporter on this story:
Felix Tam in Hong Kong at ttam59@bloomberg.net

To contact the editors responsible for this story:
Meg Shen at mshen145@bloomberg.net

Scott Lanman

© 2025 Bloomberg L.P. All rights reserved. Used with permission.

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.